SpringTide Ventures
Facts
- HQ
- Salt Lake City, Utah, US
- Sectors
- Venture Capital and Private Equity Principals
- Founded
- 2018
- Employees
- 44
Dopl Technologies raises $6.3M seed to pursue FDA clearance for Traverse remote robotic ultrasound platform
Bothell-based Dopl Technologies raised $6.3 million in seed funding from over a dozen investors to advance FDA clearance for its remote robotic ultrasound platform, including the Traverse scanner, Dopl Connect data platform and SonoFlex workflow solution. The company says the system enables sonographers to perform diagnostic ultrasounds remotely using existing hospital infrastructure, aiming to address workforce shortages and improve imaging access in rural and underserved areas.
Dopl Technologies closes $6.3M seed round led by SpringTide Ventures, total funding tops $8M to push telerobotic ultrasound toward FDA clearance
Dopl Technologies closed a $6.3 million seed round led by SpringTide Ventures, bringing total funding to over $8 million to advance its proprietary telerobotic ultrasound toward FDA clearance, funding product development, clinical evaluation, and pilot deployments.
Dopl Technologies Raises $6.3M Seed to Advance Robotic Ultrasound Platform
Dopl Technologies, a Bothell, Washington medical technology company building a robotic ultrasound platform, raised $6.3 million in a Seed funding round.
Dopl Technologies raises $6.3M seed from SpringTide Ventures to advance Traverse telerobotic ultrasound toward FDA 510(k) clearance
Dopl Technologies raised $6.3 million in seed funding led by SpringTide Ventures to advance its Traverse telerobotic ultrasound platform toward FDA 510(k) clearance, aiming to let sonographers remotely perform diagnostic exams in rural hospitals and reduce patient wait times. The company — founded in 2022 by a former Nvidia medical AI engineer and practicing cardiologists/radiologists — will use the funds for verification, validation, FDA submission, and pilot deployments while operating an interim traveling-sonographer service called CareBridge.
Dopl Technologies raises $6.3M seed to advance remote robotic ultrasound, plans FDA submission in 2027
Dopl Technologies, a Bothell, Washington startup developing a remote robotic ultrasound platform, raised $6.3 million in a seed round (more than $8 million total raised) to advance its device and regulatory work. The company, founded by CEO Ryan James with Dr. Steve Seslar and Dr. Wayne Monsky, plans an FDA submission in 2027 and says the technology could expand access to diagnostic ultrasound for millions.
Dopl Technologies raises $6.3M to advance remote robotic ultrasound system and FDA clearance efforts
Bothell, WA-based Dopl Technologies raised $6.3 million to advance its remote robotic ultrasound system, funding FDA submission/clearance, product verification and validation, clinical evaluation, and initial market release.
Dopl Technologies raises $6.3M (total >$8M) to pursue FDA clearance for remote robotic ultrasound system
Dopl Technologies raised $6.3 million (bringing total funding to over $8 million) to develop and commercialize a remotely operated robotic ultrasound system that pairs off-the-shelf probes with commercial robots and supports remote sonographers via haptic feedback and video. The Bothell, Wash. startup is pursuing FDA clearance and conducting clinical evaluations to target rural and underserved communities.
Dopl Technologies raises $6.3M seed round led by SpringTide Ventures, total funding tops $8M to push robotic ultrasound toward FDA clearance
Dopl Technologies closed a $6.3 million seed round led by SpringTide Ventures, bringing total funding to over $8 million to advance its remote robotic ultrasound platform toward FDA clearance. The funds will support product development, clinical evaluation, regulatory submission, and initial pilot deployments of its Traverse, Dopl Connect, and SonoFlex offerings.
